Inetetamab Treatment for Liver Oligometastases of HER2-Positive Breast Cancer: A Case Report and Literature Review

Inetetamab Treatment for Liver Oligometastases of HER2-Positive Breast Cancer: A Case Report and Literature Review

Bibliographic Details
Main Authors:	XIE Xiaofeng, BAI Xue, LAN Xiaofeng, LI Muli, DU Caiwen
Format:	Article
Language:	zho
Published:	Magazine House of Cancer Research on Prevention and Treatment 2023-10-01
Series:	Zhongliu Fangzhi Yanjiu
Online Access:	http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.23.0430

Similar Items

Systemic investigation of inetetamab in combination with small molecules to treat HER2-overexpressing breast and gastric cancers
by: Deng Lan, et al.
Published: (2023-01-01)

Efficacy and safety of inetetamab-containing regimens in patients with HER2-positive metastatic breast cancer: a real-world retrospective study in China
by: Xiaoyu Liu, et al.
Published: (2023-06-01)

The anti-tumor efficiency of low-dose apatinib-based chemotherapy in pretreated HER2-negative breast cancer with brain metastases
by: Xuelian Chen, et al.
Published: (2023-12-01)

Exploring the clinical outcomes and safety profile of inetetamab treatment in metastatic breast cancer patients: A multicenter assessment of a Chinese-origin recombinant Anti-HER2 monoclonal antibody
by: Binliang Liu, et al.
Published: (2023-12-01)

Stereotactic body radiotherapy for oligometastases.
by: Tree, A, et al.
Published: (2013)

Are all colorectal oligometastases equal?
by: O'Cathail, S, et al.
Published: (2018)

Inetetamab combined with pyrotinib and oral vinorelbine for patients with human epidermal growth factor receptor 2 positive advanced breast cancer: A single-arm phase 2 clinical trial
by: Nan Jin, et al.
Published: (2024-01-01)

TROP2 overexpression in colorectal liver oligometastases is associated with poor prognosis after liver resection
by: Jianhong Peng, et al.
Published: (2019-12-01)

Inetetamab in combination with rapamycin and chemotherapy for trastuzumab‐treated metastatic human epidermal growth factor receptor 2‐positive breast cancer with abnormal activation of PI3K/Akt/mTOR pathway
by: Aijuan Wang, et al.
Published: (2023-09-01)

Preclinical and clinical applications of specific molecular imaging for HER2-positive breast cancer
by: Wei Chen, et al.
Published: (2017-06-01)

The Yin and Yang of Cytoreductive SBRT in Oligometastases and Beyond
by: Benjamin E. Onderdonk, et al.
Published: (2019-08-01)

IDO1/COX2 Expression Is Associated with Poor Prognosis in Colorectal Cancer Liver Oligometastases
by: Miaoqing Wu, et al.
Published: (2023-03-01)

Combination of Palbociclib and Endocrine Therapy in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer With or Without Brain Metastases
by: Qiuyi Zhang MD, et al.
Published: (2024-01-01)

Oligometastases of Esophageal Squamous Cell Carcinoma: A Review
by: Yuta Sato, et al.
Published: (2024-02-01)

The Road to Dissemination: The Concept of Oligometastases and the Barriers for Widespread Disease
by: Hamza AlGhamdi, et al.
Published: (2022-04-01)

Stereotactic body radiation therapy in patients with liver oligometastases from colorectal cancer: a systematic review
by: A. N. Moskalenko, et al.
Published: (2022-04-01)

Long-term survival of two patients with pancreatic cancer after resection of liver and lung oligometastases: a case report
by: Kei Hagiwara, et al.
Published: (2020-12-01)

Stereotactic Body Radiation Therapy for Lung and Liver Oligometastases from Breast Cancer: Toxicity Data of a Prospective Non-Randomized Phase II Trial
by: Davide Franceschini, et al.
Published: (2022-10-01)

Local Control Following Stereotactic Body Radiation Therapy for Liver Oligometastases: Lessons from a Quarter Century
by: Sara Mheid, et al.
Published: (2023-10-01)

Optimizing Treatment Strategy for Oligometastases/Oligo-Recurrence of Colorectal Cancer
by: Ryoma Yokoi, et al.
Published: (2023-12-01)

Oligometastases: We Have a Hammer, but What Exactly is the Nail?
by: Ibrahim Abu-Gheida, et al.
Published: (2020-05-01)

Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases
by: Goda G. Kalinauskaite, et al.
Published: (2020-05-01)

Role of Radiosurgery/Stereotactic Radiotherapy in Oligometastatic Disease: Brain Oligometastases
by: Rosario Mazzola, et al.
Published: (2019-04-01)

Disitamab Vedotin (RC48) for HER2-positive advanced breast cancer: a case report and literature review
by: Yang Li, et al.
Published: (2023-11-01)

High-grade HER2-positive mucoepidermoid carcinoma of the breast: a case report and review of the literature
by: Mario Della Mura, et al.
Published: (2023-12-01)

HER2 positive mucinous carcinoma of breast with micropapillary features: Report of a case and review of literature
by: Dinesh Chandra Doval, et al.
Published: (2021-09-01)

HER2-Positive Conversion in a Metastatic Liver Focus in Late Recurrent Breast Cancer
by: Miyuki Kitahara, et al.
Published: (2019-06-01)

Immunotherapy for HER-2 positive breast cancer
by: Tingting Yang, et al.
Published: (2023-03-01)

Stereotactic Body Radiation Therapy in Gynecologic Oligometastases: An Effective but Underutilized Approach
by: Zohaib Sherwani, et al.
Published: (2023-07-01)

Phase II trial of concurrent sunitinib and image-guided radiotherapy for oligometastases.
by: Charles C L Tong, et al.
Published: (2012-01-01)

Bilateral inflammatory recurrence of HER-2 positive breast cancer: a unique case report and literature review
by: Rong Qin, et al.
Published: (2024-01-01)

Evaluating the expression of HMGCR in HER2 negative and HER2 positive breast cancer
by: Drahman, Rosmaizan
Published: (2022)

Local Treatment of Hepatocellular Carcinoma with Oligometastases: A Systematic Review and Meta-Analysis
by: Sooyeon Kim, et al.
Published: (2023-07-01)

Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
by: Gregor Habl, et al.
Published: (2017-05-01)

Immunological Landscape of HER-2 Positive Breast Cancer
by: Santiago Moragon, et al.
Published: (2022-06-01)

Immunotherapies against HER2-Positive Breast Cancer
by: Santiago Duro-Sánchez, et al.
Published: (2023-02-01)

Educational Case: HER-2 Positive Breast Cancer
by: Julia Jennings MD, et al.
Published: (2021-09-01)

Interlaboratory concordance in HER-2 positive breast cancer
by: Nives Jonjić, et al.
Published: (2015-01-01)

Treatment of HER2 positive breast cancer patients
by: Erika Matos
Published: (2012-03-01)

Neoadjuvant therapy for HER2-positive breast cancer
by: Nikolina Dukić, et al.
Published: (2019-06-01)